ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,874Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 546

$793K Total Retail Price of All Prescriptions

Rank: 11 out of 546

691 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maine
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 691 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

16% of this provider’s 691 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 9,961 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $65 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maine
SIMVASTATIN 550 445 1 2
OMEPRAZOLE 511 376 2 4
HYDROCODONE-ACETAMINOPHEN 474 198 S3 3 8
LISINOPRIL 468 368 4 1
HYDROCHLOROTHIAZIDE 392 331 5 7
AMLODIPINE BESYLATE 380 310 6 9
LEVOTHYROXINE SODIUM 379 276 7 3
METFORMIN HCL 318 249 8 10
METOPROLOL TARTRATE 259 212 9 6
FUROSEMIDE 255 213 10 5
ATENOLOL 249 219 11 12
ATORVASTATIN CALCIUM 238 195 12 11
SERTRALINE HCL 193 157 13 14
WARFARIN SODIUM 172 145 14 13
TAMSULOSIN HCL 164 136 15 35
TRAZODONE HCL 154 117 16 25
FAMOTIDINE 143 65 17 53
GABAPENTIN 143 91 17 16
ZOLPIDEM TARTRATE 140 71 19 26
METOPROLOL SUCCINATE 137 136 20 17
OXYCODONE HCL 124 36 S2 21 15
POTASSIUM CHLORIDE 123 91 22 30
METHADONE HCL 115 31 S2 23 61
FLUTICASONE PROPIONATE 110 70 24 42
LOVASTATIN 103 91 25 22
TRAMADOL HCL 102 66 26 19
SPIRIVA 100 74 27 28
CRESTOR 100 95 27 36
OXYBUTYNIN CHLORIDE ER 95 74 29 105
PREDNISONE 95 83 29 29
GLIPIZIDE 94 81 31 44
AZITHROMYCIN 93 67 32 55
METFORMIN HCL ER 92 90 33 74
GLYBURIDE 88 77 R 34 45
DONEPEZIL HCL 88 88 34 31
LOSARTAN POTASSIUM 84 71 36 24
PROAIR HFA 84 58 36 27
JANTOVEN 83 69 38 92
ALENDRONATE SODIUM 81 78 39 38
MIRTAZAPINE 81 57 39 51
VENLAFAXINE HCL ER 79 25 41 88
ADVAIR DISKUS 79 67 41 20
TIZANIDINE HCL 77 25 43 175
ESCITALOPRAM OXALATE 77 60 43 66
MELOXICAM 76 51 45 58
TRIAMCINOLONE ACETONIDE 76 60 45 112
ENALAPRIL MALEATE 76 57 45 59
DIGOXIN 71 60 48 62
FINASTERIDE 71 62 48 94
PRAVASTATIN SODIUM 70 46 50 33
RISPERIDONE 69 22 51 47
ISOSORBIDE MONONITRATE ER 69 62 51 32
JANUVIA 66 57 53 79
CEPHALEXIN 66 43 53 111
ZOSTAVAX 65 59 55 164
IBUPROFEN 65 12 55 70
FLUOXETINE HCL 65 33 55 39
NEXIUM 64 40 58 52
LANTUS 64 50 58 46
PANTOPRAZOLE SODIUM 63 43 60 18
CITALOPRAM HBR 62 37 61 21
AMITRIPTYLINE HCL 62 17 R 61 48
PAROXETINE HCL 59 38 63 43
OXYCODONE-ACETAMINOPHEN 58 32 S2 64 54
PLAVIX 58 54 64 116
PROMETHAZINE HCL 57 20 R 66 119
LISINOPRIL-HYDROCHLOROTHIAZIDE 55 54 67 49
KLOR-CON M10 51 40 68 118
FENTANYL 51 42 S2 68 50
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 16, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.